• Tue, May 24, 2022
Tiago Fauth Maintained (UTHR) at Buy with Increased Target to $247 on, May 24th, 2022
Tiago Fauth of Credit Suisse, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $219 to $247 on, May 24th, 2022.
Tiago has made no other calls on UTHR in the last 4 months.
There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Julian Harrison of "BTIG" Initiated at Hold on, Friday, February 11th, 2022
This is the rating of the analyst that currently disagrees with Tiago
- Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Decreased Target to $203 on, Friday, February 25th, 2022
Like: 👍
